GSK plc Logo

GSK plc

Develops specialty medicines and vaccines to prevent and treat a range of global diseases.

GSK | US

Overview

Corporate Details

ISIN(s):
GB0009252882
LEI:
Country:
United States of America
Address:
79 NEW OXFORD STREET, 0 LONDON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to prevent and treat disease. The company researches, develops, and manufactures a portfolio of specialty medicines and vaccines. Its primary R&D is concentrated in four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases. Leveraging advancements in immunology and human genetics, GSK aims to deliver transformative treatments. The company is also committed to expanding global health access by making its products more affordable and available through strategic partnerships and responsible pricing programs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-04 13:10
Foreign Filer Report
6-K - GSK plc (0001131399) (Filer)
English 62.0 KB

Automate Your Workflow. Get a real-time feed of all GSK plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GSK plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GSK plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
MediciNova,Inc. Logo
Developing small-molecule drugs for neurology, respiratory, and liver diseases.
Japan 4875
Medicon Hellas S.A. Logo
Develops, makes, and sells IVD products, analytical systems & software for healthcare providers.
Greece MEDIC
MEDICOX Co., Ltd. Logo
Developing new drugs and building a distribution platform for healthcare solutions.
South Korea 054180
Medicus Pharma Ltd. Logo
A clinical-stage holding company advancing novel drugs, biologics, and devices to market.
United States of America MDCX
Medigene AG Logo
Clinical-stage immuno-oncology firm developing TCR-engineered T cell therapies for solid tumors.
Germany MDG1
MedinCell S.A. Logo
Develops long-acting injectable therapies using proprietary technology to impact global health.
France MEDCL
A CDMO for cell therapy and regenerative medicine development & manufacturing.
Japan 2370
Medios AG Logo
Compounding patient-specific therapies and supplying specialty pharma for complex conditions.
Germany ILM1
Develops cord blood stem cell therapies for osteoarthritis & infant lung disease, plus banking.
South Korea 078160
MediWound Ltd. Logo
Develops enzymatic therapies for non-surgical tissue repair in burns and chronic wounds.
United States of America MDWD

Talk to a Data Expert

Have a question? We'll get back to you promptly.